Drug development
A strategic agreement to accelerate the development of new drugs
David Andreu (DCEXS-UPF): “Cannabis co-administered with the drug we have developed would offer analgesia without cognitive side effects”
Iris Lioba Matilla Vaz (IMIM): “Without clinical trials, medicine could not move forward”
Deciphering the cell signalling code: the role of β-arrestins
Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2
Inside out: looking within our bodies improves drug design
Manuel Pastor: “We have created one of the world’s largest toxicology database”
Animals in biomedical research
Ferran Sanz: “Habitual competitors are now working together to get better toxicity predictions”
David Searls: “Personalised medicine and Big Pharma need bioinformatics”
